-
1
-
-
0346731073
-
Maillard reaction products in tissue proteins : New products and new perspectives
-
Thorpe SR, Baynes JW : Maillard reaction products in tissue proteins : new products and new perspectives. Amino Acids 25 : 275-281, 2003
-
(2003)
Amino Acids
, vol.25
, pp. 275-281
-
-
Thorpe, S.R.1
Baynes, J.W.2
-
2
-
-
4644231051
-
Lipoproteins and diabetic microvascular complications
-
Jenkins AJ, Rowley KG, Lyons TJ, Best JD, Hill MA, Klein RL : Lipoproteins and diabetic microvascular complications. Curr Pharm Des 10 : 3395-3418, 2004
-
(2004)
Curr Pharm Des
, vol.10
, pp. 3395-3418
-
-
Jenkins, A.J.1
Rowley, K.G.2
Lyons, T.J.3
Best, J.D.4
Hill, M.A.5
Klein, R.L.6
-
3
-
-
4644371176
-
Lipoproteins, glycoxidation and diabetic angiopathy
-
Jenkins AJ, Best JD, Klein RL, Lyons TJ : 'Lipoproteins, glycoxidation and diabetic angiopathy'. Diabetes Metab Res Rev 20 : 349-368, 2004
-
(2004)
Diabetes Metab Res Rev
, vol.20
, pp. 349-368
-
-
Jenkins, A.J.1
Best, J.D.2
Klein, R.L.3
Lyons, T.J.4
-
4
-
-
10644246127
-
Advanced glycation end-product cross-link breakers : A novel approach to cardiovascular pathologies related to the aging process
-
Bakris GL, Bank AJ, Kass DA, Neutel JM, Preston RA, Oparil S : Advanced glycation end-product cross-link breakers : a novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 17 : 23S-30S, 2004
-
(2004)
Am J Hypertens
, vol.17
-
-
Bakris, G.L.1
Bank, A.J.2
Kass, D.A.3
Neutel, J.M.4
Preston, R.A.5
Oparil, S.6
-
5
-
-
0942290502
-
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat
-
Davis BJ, Forbes JM, Thomas MC, Jerums G, Burns WC, Kawachi H, Allen TJ, Cooper ME : Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia 47 : 89-97, 2004
-
(2004)
Diabetologia
, vol.47
, pp. 89-97
-
-
Davis, B.J.1
Forbes, J.M.2
Thomas, M.C.3
Jerums, G.4
Burns, W.C.5
Kawachi, H.6
Allen, T.J.7
Cooper, M.E.8
-
6
-
-
33748292943
-
The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes : An update
-
Lapolla A, Fedele D, Seraglia R, Traldi P : The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes : An update. Mass Spectrom Rev, 2006
-
(2006)
Mass Spectrom Rev
-
-
Lapolla, A.1
Fedele, D.2
Seraglia, R.3
Traldi, P.4
-
7
-
-
0038675088
-
Serum levels of low molecular weight advanced glycation end products in diabetic subjects
-
Sharp PS, Rainbow S, Mukherjee S : Serum levels of low molecular weight advanced glycation end products in diabetic subjects. Diabet Med 20 : 575-579, 2003
-
(2003)
Diabet Med
, vol.20
, pp. 575-579
-
-
Sharp, P.S.1
Rainbow, S.2
Mukherjee, S.3
-
8
-
-
4344686855
-
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes
-
Thomas MC, Tsalamandris C, MacIsaac R, Medley T, Kingwell B, Cooper ME, Jerums G : Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int 66 : 1167-1172, 2004
-
(2004)
Kidney Int
, vol.66
, pp. 1167-1172
-
-
Thomas, M.C.1
Tsalamandris, C.2
MacIsaac, R.3
Medley, T.4
Kingwell, B.5
Cooper, M.E.6
Jerums, G.7
-
9
-
-
0041823228
-
Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl) lysine ELISA
-
Galler A, Muller G, Schinzel R, Kratzsch J, Kiess W, Munch G : Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl) lysine ELISA Diabetes Care 26 : 2609-2615, 2003
-
(2003)
Diabetes Care
, vol.26
, pp. 2609-2615
-
-
Galler, A.1
Muller, G.2
Schinzel, R.3
Kratzsch, J.4
Kiess, W.5
Munch, G.6
-
10
-
-
0025938891
-
Advanced glycosylation end products in patients with diabetic nephropathy
-
Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H : Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325 : 836-842, 1991
-
(1991)
N Engl J Med
, vol.325
, pp. 836-842
-
-
Makita, Z.1
Radoff, S.2
Rayfield, E.J.3
Yang, Z.4
Skolnik, E.5
Delaney, V.6
Friedman, E.A.7
Cerami, A.8
Vlassara, H.9
-
11
-
-
0035025293
-
Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients
-
Stein G, Franke S, Mahiout A, Schneider S, Sperschneider H, Borst S, Vienken J : Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol Dial Transplant 16 : 999-1008, 2001
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 999-1008
-
-
Stein, G.1
Franke, S.2
Mahiout, A.3
Schneider, S.4
Sperschneider, H.5
Borst, S.6
Vienken, J.7
-
12
-
-
23744470200
-
Plasma low-molecular weight fluorescence in type 1 diabetes mellitus
-
Januszewski AS, Thomas MC, Chung SJ, Karschimkus CS, Rowley KG, Nelson C, O'Neal D, Wang Z, Best JD, Jenkins AJ : Plasma low-molecular weight fluorescence in type 1 diabetes mellitus. Ann NY Acad Sci 1043 : 655-661, 2005
-
(2005)
Ann NY Acad Sci
, vol.1043
, pp. 655-661
-
-
Januszewski, A.S.1
Thomas, M.C.2
Chung, S.J.3
Karschimkus, C.S.4
Rowley, K.G.5
Nelson, C.6
O'Neal, D.7
Wang, Z.8
Best, J.D.9
Jenkins, A.J.10
-
13
-
-
1842614404
-
Comparison of arterial assessments in low and high vascular disease risk groups
-
Wilson AM, O'Neal D, Nelson CL, Prior DL, Best JD, Jenkins AJ : Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens 17 : 285-291, 2004
-
(2004)
Am J Hypertens
, vol.17
, pp. 285-291
-
-
Wilson, A.M.1
O'Neal, D.2
Nelson, C.L.3
Prior, D.L.4
Best, J.D.5
Jenkins, A.J.6
-
14
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Cockcroft DW, Gault MH : Prediction of creatinine clearance from serum creatinine. Nephron 16 : 31-41, 1976
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
-
15
-
-
0026781518
-
Predicting glomerular function from adjusted serum creatinine
-
Gault MH, Longerich LL, Harnett JD, Wesolowski C : Predicting glomerular function from adjusted serum creatinine. Nephron 62 : 249-256, 1992
-
(1992)
Nephron
, vol.62
, pp. 249-256
-
-
Gault, M.H.1
Longerich, L.L.2
Harnett, J.D.3
Wesolowski, C.4
-
16
-
-
23744474803
-
Advanced glycation in health and disease : Role of the modern environment
-
Vlassara H : Advanced glycation in health and disease : role of the modern environment. Ann NY Acad Sci 1043 : 452-460, 2005
-
(2005)
Ann NY Acad Sci
, vol.1043
, pp. 452-460
-
-
Vlassara, H.1
-
17
-
-
0142044013
-
Role of lipids in chemical modification of proteins and development of complications in diabetes
-
Januszewski AS, Alderson NL, Metz TO, Thorpe SR, Baynes JW : Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem Soc Trans 31 : 1413-1416, 2003
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 1413-1416
-
-
Januszewski, A.S.1
Alderson, N.L.2
Metz, T.O.3
Thorpe, S.R.4
Baynes, J.W.5
-
18
-
-
0030876360
-
Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system
-
Wrobel K, Garay-Sevilla ME, Nava LE, Malacara JM : Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem 43 : 1563-1569, 1997
-
(1997)
Clin Chem
, vol.43
, pp. 1563-1569
-
-
Wrobel, K.1
Garay-Sevilla, M.E.2
Nava, L.E.3
Malacara, J.M.4
-
19
-
-
0033770156
-
Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis
-
Gerdemann A, Lemke HD, Nothdurft A, Heidland A, Munch G, Bahner U, Schinzel R : Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Clin Nephrol 54 : 276-283, 2000
-
(2000)
Clin Nephrol
, vol.54
, pp. 276-283
-
-
Gerdemann, A.1
Lemke, H.D.2
Nothdurft, A.3
Heidland, A.4
Munch, G.5
Bahner, U.6
Schinzel, R.7
-
20
-
-
0028286374
-
Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
-
Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA Fuh H, Manogue KR, Cerami A, Vlassara H : Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343 : 1519-1522, 1994
-
(1994)
Lancet
, vol.343
, pp. 1519-1522
-
-
Makita, Z.1
Bucala, R.2
Rayfield, E.J.3
Friedman, E.A.4
Kaufman, A.M.5
Korbet, S.M.6
Barth, R.H.7
Winston, J.A.8
Fuh, H.9
Manogue, K.R.10
Cerami, A.11
Vlassara, H.12
-
21
-
-
0036830463
-
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy
-
Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, Osicka TM : Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51 : 3274-3282, 2002
-
(2002)
Diabetes
, vol.51
, pp. 3274-3282
-
-
Forbes, J.M.1
Cooper, M.E.2
Thallas, V.3
Burns, W.C.4
Thomas, M.C.5
Brammar, G.C.6
Lee, F.7
Grant, S.L.8
Burrell, L.A.9
Jerums, G.10
Osicka, T.M.11
-
22
-
-
0036599334
-
Advanced glycation end products and endothelial dysfunction in type 2 diabetes
-
Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS : Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25 : 1055-1059, 2002
-
(2002)
Diabetes Care
, vol.25
, pp. 1055-1059
-
-
Tan, K.C.1
Chow, W.S.2
Ai, V.H.3
Metz, C.4
Bucala, R.5
Lam, K.S.6
-
23
-
-
0031847514
-
The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules
-
Kunt T, Forst T, Harzer O, Buchert G, Pfutzner A, Lobig M, Zschabitz A, Stofft E, Engelbach M, Beyer J : The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Exp Clin Endocrinol Diabetes 106 : 183-188, 1998
-
(1998)
Exp Clin Endocrinol Diabetes
, vol.106
, pp. 183-188
-
-
Kunt, T.1
Forst, T.2
Harzer, O.3
Buchert, G.4
Pfutzner, A.5
Lobig, M.6
Zschabitz, A.7
Stofft, E.8
Engelbach, M.9
Beyer, J.10
-
24
-
-
4043058031
-
Advanced glycation end products and vascular inflammation : Implications for accelerated atherosclerosis in diabetes
-
Basta G, Schmidt AM, De Caterina R : Advanced glycation end products and vascular inflammation : implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63 : 582-592, 2004
-
(2004)
Cardiovasc Res
, vol.63
, pp. 582-592
-
-
Basta, G.1
Schmidt, A.M.2
De Caterina, R.3
-
25
-
-
0034659178
-
Glycoxidation and lipoxidation in atherogenesis
-
Baynes JW, Thorpe SR : Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28 : 1708-1716, 2000
-
(2000)
Free Radic Biol Med
, vol.28
, pp. 1708-1716
-
-
Baynes, J.W.1
Thorpe, S.R.2
-
26
-
-
0242468729
-
Quantitative screening of advanced glycation end-products in cellular and extracellular proteins by tandem mass spectrometry
-
Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A : Quantitative screening of advanced glycation end-products in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375 : 581-592, 2003
-
(2003)
Biochem J
, vol.375
, pp. 581-592
-
-
Thornalley, P.J.1
Battah, S.2
Ahmed, N.3
Karachalias, N.4
Agalou, S.5
Babaei-Jadidi, R.6
Dawnay, A.7
|